Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652824 | SCV000774696 | likely benign | Noonan syndrome 9 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440370 | SCV002677882 | likely benign | Cardiovascular phenotype | 2022-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000652824 | SCV002763108 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV003389824 | SCV004134089 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | SOS2: BP4, BP7 |